Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus.
Cardiovascular risk
Glycation
Inflammation
Novel biomarkers
Oxidative stress
Type 2 diabetes mellitus
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
received:
22
09
2020
revised:
15
03
2021
accepted:
13
04
2021
pubmed:
24
4
2021
medline:
18
11
2021
entrez:
23
4
2021
Statut:
ppublish
Résumé
Diabetes represents the leading risk factor for the development of cardiovascular disease (CVD). Chronic hyperglycemia and/or acute post-prandial changes in blood glucose determine an increase in reactive oxygen species (ROS), which play a fundamental role in endothelial dysfunction and in the nuclear transport of pro-atherogenic transcription factors that activate the "inflammasome". In addition, the glycemic alteration favors the formation and stabilization of atherosclerotic plaque through the mechanism of non-enzymatic glycation of different molecules, with the establishment of the so-called "advanced glycosylation end products" (AGE). Laboratory information provided by the level of biomarkers could make a quantitative and qualitative contribution to the clinical process of screening, prediction, prevention, diagnosis, prognosis and monitoring of cardiovascular (CV) risk linked to diabetes. This review describes the importance of specific biomarkers, with particular focus on novel ones, for stratifying and management of diabetes CV risk.
Identifiants
pubmed: 33892081
pii: S0925-4439(21)00081-8
doi: 10.1016/j.bbadis.2021.166148
pii:
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Reactive Oxygen Species
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
166148Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.